B
동국제약
086450KOSDAQ64.5 / 100
Reference Date: 2026-10-23
Financial Score26.0 / 40
News Sentiment12.5 / 25
Momentum16.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and ROE is above the industry average is also solid. Rose 13.5% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Dongkook Pharmaceutical, established in 1968, aims to become South Korea's leading total healthcare group by focusing on new product development and global market expansion. The company offers a wide range of products in over-the-counter drugs, specialty pharmaceuticals, and healthcare sectors, and has successfully exported its products to countries such as China, Japan, and Europe.
Number of Employees
1,306people
Average Salary
67.6M KRW
Score Calculation Basis
Detailed Financial Score
PER
15.84Industry Average 15.003.0Point
Higher than industry avg (caution)
PBR
1.39Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
10.25Industry Average 8.004.0Point
In line with industry avg
Debt Ratio
4.16Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20258.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲12.6% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲20.2% (2-year basis)
ROE Trend
3.0 / 4
Avg ROE 9.7% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position5.0Point
52w mid range (52%)
Current 23,550Won52-week high 29,90052-week low 16,420
1-month return5.0Point
1m +13.49% (rising)
Volume trend6.0Point
Volume surge
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral주주명부폐쇄기간또는기준일설정2026-10-12
- Neutral주주총회소집결의 (임시주주총회)2026-10-12